Financial News

Financial Report: PRA Health Sciences

Revenues up 7% in the quarter

By: Kristin Brooks

Managing Editor, Contract Pharma

PRA Health Sciences
 
3Q Revenues:
$403.5 million (+7%)

3Q Earnings: $23.7 million (earnings were $1.2 million 3Q14)

YTD Revenues: $1.2 billion (+9%)

YTD Earnings: $53.3 million (loss of $12.9 million YTD14)

Comments: Net new business for the quarter ended September 30, 2015 was $431.4 million, representing a book-to-bill ratio of 1.25 for the period. This net new business contributed to an ending backlog of $2.3 billion at September 30, 2015.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters